Search results - 8 results

Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.

risk of developing severe disease. This is challenging, however, since effective mRNA vaccination requires the successful cooperation of several components of the innate and adaptive immune systems, both ...

Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.

Viral Biomarkers BNT162 Vaccine COVID-19 Vaccines Humans Immunity, Humoral Immunization Schedule Immunization, Secondary Immunogenicity, Vaccine Neoplasms Prospective Studies Risk Factors Time Factors ...

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.

Count Coinfection Double-Blind Method Female Healthy Volunteers HIV Infections Hiv-1 Humans Immunity, Active Immunization, Secondary Immunoglobulin G Injections, Intradermal Male middle aged Mycobacterium ...

Immunogenicity and protective efficacy of DNA vaccines encoding MAP0586c and MAP4308c of Mycobacterium avium subsp. paratuberculosis secretome.

Humans Immunization, Secondary Immunoglobulin G mice Mice, Inbred BALB C Mice, Inbred C57BL Mycobacterium avium subsp. paratuberculosis Paratuberculosis Plasmids T-Lymphocytes Th1 Cells Vaccines, DNA ...

The perinatal presence of antigen (p-azophenylarsonate) or anti-mu antibodies lead to the loss of the recurrent idiotype (CRIA) in A/J mice.

Volume 7, Issue 4 (1995) Keywords: Animals Animals, Newborn Antibodies, Anti-Idiotypic Antibody Affinity gamma-Globulins Immune Tolerance Immunoglobulin Idiotypes Immunoglobulin M Lymphocyte Count mice ...

QR code

QR code for this page URL